Omega Weight Loss Center
228 South Orange Avenue · South Orange Village, NJ 07079
4.9(29 Google reviews)
Accepts insurance
Listing updated Oct 2, 2026
Endure Health and Wellness: Weight Loss, Testosterone, ED, PE, Vitamin Shot, NAD+
Endure Health and Wellness: Weight Loss, Testosterone, ED, PE, Vitamin Shot, NAD+ · 111 South Orange Avenue · South Orange Village, NJ 07079
5.0· 12 Google reviews
Listing updated October 2, 2026
Retatrutide outlook for this practice
No current plans confirmed — RetaMaps has not yet confirmed this practice's intentions regarding retatrutide. Inclusion on RetaMaps does not mean the provider offers or will offer retatrutide.
About this practice
Endure Health and Wellness is a direct primary care practice in South Orange Village, New Jersey that, per its website, replaces insurance billing with one flat monthly membership and offers same-day or next-day access and longer visits for families, professionals and businesses in Essex and Union Counties. Its site introduces co-founders Dr. Candacy George, DO, a board-certified family medicine physician, and Calvin George, MSN, APRN, FNP-C, PMHNP-BC, and notes add-on lifestyle medicine and optimization services for members at an additional cost. On Google it has a 5.0-star rating across 12 reviews dating back to 2023, with one in the past year and single mentions of the staff and knowledge.
Services & access
| Advertises semaglutide today | Not listed |
| Advertises tirzepatide today | Not listed |
| Telehealth visits | Not listed |
| Cash pay accepted | Yes |
| Accepts insurance — per practice website | Not listed |
| Accepting new patients — per practice website | Yes |
"Not listed" means we didn't find this stated on the practice's public pages — it doesn't mean no. — means unknown. Medication rows describe currently FDA-approved GLP-1 medications the practice advertises today, not retatrutide. Confirm details directly with the practice.
Review activity
★ 5.0
Google rating · 12 reviews
1
reviews in the past year (avg ★ 5.0)
Counts computed by RetaMaps from public Google reviews; most recent review 2026-03-17. Read the reviews themselves on the practice's Google listing.
What patients say
Rated ★5.0 across 12 Google reviews. Of the 9 reviews we analyzed, 9 (100%) are positive (4–5★) and 0 (0%) are negative (1–2★).
5★
9
4★
0
3★
0
2★
0
1★
0
Most recent Google reviews
Barbara H.★★★★★2026-03-17Excellent source for supporting health optimization using peptides!
Alexis C.★★★★★2024-12-23Dr. Calvin is AWESOME!!!! Easy to talk to and extremely knowledgeable. Definitely one of the best medical experiences I’ve had and I look forward to many more. Highly recommended.
Onyi O.★★★★★2024-09-23Amazing service! I would definitely recommend Calvin to all my friends
Nairoly H.★★★★★2024-09-05Dr. Calvin George takes your time with you. Fully explains everything. Friendly, courteous and easy to work with when it comes to explaining things in details.
C C.★★★★★2024-02-19Great service. Calvin worked with me to achieve my goal by providing guidance and support on demand. I highly recommend Endure health and wellness.
Analysis by RetaMaps of reviews on this practice's public Google Business listing; review themes are detected automatically and reviews reflect their authors' opinions. See all reviews on Google.
Nearby providers in South Orange Village
Retatrutide status
Phase 3 complete · Not FDA-approvedUpdated October 2, 2026
Retatrutide is Eli Lilly's investigational once-weekly triple agonist (GIP, GLP-1 and glucagon receptors). Five Phase 3 trials have reported positive results, and Lilly plans to submit it to the FDA in Q1 2027. It is not FDA-approved, has no brand name or price, and cannot be prescribed outside clinical trials or Lilly's physician-requested expanded access program. Products sold online as "research" or compounded retatrutide are not legitimate retatrutide.
- Development
- Phase 3 complete
- FDA status
- Submission planned — Q1 2027 (Lilly guidance)
- Availability
- Not commercially available
- Access routes
- Clinical trials, or Lilly's expanded access program (physician must apply)
Next milestone: TRIUMPH-5 head-to-head vs tirzepatide results (Expected ~Dec 2026)
Sources: Lilly — What to know about retatrutide · Lilly — TRIUMPH-2/TRIUMPH-3 results · BioPharma Dive — FDA submission plans · STAT — Lilly expanded access (Aug 3, 2026) · FDA — Concerns with unapproved GLP-1 drugs